Filing Flows › Health Care › Alcon (ALC)
Alcon (ALC) earnings and revenue breakdown
Latest: Q2 2026 · 6-K filed Aug 10, 2026 · Alcon (ALC) Q2 2026 earnings results →
Q2 2026 Revenue up 9% year over year to $2.8B · 0¢ of every $1 of revenue kept as net profit · operating margin 0.4%
Alcon made $2.8B in Q2 2026 (+9% Y/Y). Operating margin 0.4%, net earnings $0. See where every dollar goes — costs, profit and cash — as a Sankey from the 6-K filed Aug 10, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $2.8B in Q2 2026, up 9% year over year and up 4% from the previous quarter.
Gross margin was 59.3%, up 5.9 points from a year earlier. Operating profit was $0.01B, a 0.4% margin (down 9.1 points year over year). Operating profit fell $0.24B even though revenue rose $0.23B versus a year earlier, so costs grew faster than sales. Operating expenses grew 46% against revenue growth of 9%. The fastest-growing cost line was Research & development (+171%). Net earnings were $0K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 6-K | Aug 10, 2026 | $2.8B | +9% | 0.4% | $0 | — |
| Q1 2026 | 6-K | May 5, 2026 | $2.7B | +9% | 10.8% | $189M | — |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Alcon
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of people in over 140 countries and territories each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com .
In its own words, from its 6-K, filed Aug 10, 2026.
Alcon against its Ophthalmic Goods peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +9% against the peers' median +7%. Operating margin: 0.4% against the peers' median 4.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| ALC Alcon | Q2 2026 | $2.8B | +9% | 0.4% |
| BLCO Bausch & Lomb | Q3 2026 | $1.4B | +7% | 11.3% |
| COO Cooper Companies | Q3 FY26 | $1.1B | +0.6% | 20.8% |
| EYE National Vision Holdings | Q2 2026 | $499M | +2% | 4.3% |
| WRBY Warby Parker | Q3 2026 | $245M | +10% | 1.5% |
| STAA Staar Surgical | Q3 2026 | $83.4M | -12% | 6.5% |
| RXST RxSight | Q3 2026 | $24.6M | -19% | -75.3% |
| LUCYW Innovative Eyewear | Q2 2026 | $1.0M | +74% | -165.3% |
Source: Alcon 6-K on SEC EDGAR · CIK 1167379 · Ophthalmic Goods
More on ALC
History
Every quarter: Q2 2026 results · Q1 2026 results